Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Broadly neutralizing DNA vaccine with specific mutation alters the antigenicity and sugar-binding activities of influenza hemagglutinin

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Chen, M. W.
  • Liao, H. Y.
  • Huang, Y. X.
  • Jan, J. T.
  • Huang, C. C.
  • Ren, C. T.
  • Wu, Chunlei
  • Cheng, T. J. R.
  • Ho, D. D.
  • Wong, Chi-Huey

publication date

  • March 2011

journal

  • Proceedings of the National Academy of Sciences of the United States of America  Journal

abstract

  • The rapid genetic drift of influenza virus hemagglutinin is an obstacle to vaccine efficacy. Previously, we found that the consensus hemagglutinin DNA vaccine (pCHA5) can only elicit moderate neutralization activities toward the H5N1 clade 2.1 and clade 2.3 viruses. Two approaches were thus taken to improve the protection broadness of CHA5. The first one was to include certain surface amino acids that are characteristic of clade 2.3 viruses to improve the protection profiles. When we immunized mice with CHA5 harboring individual mutations, the antibodies elicited by CHA5 containing P157S elicited higher neutralizing activity against the clade 2.3 viruses. Likewise, the viruses pseudotyped with hemagglutinin containing 157S became more susceptible to neutralization. The second approach was to update the consensus sequence with more recent H5N1 strains, generating a second-generation DNA vaccine pCHA5II. We showed that pCHA5II was able to elicit higher cross-neutralization activities against all H5N1 viruses. Comparison of the neutralization profiles of CHA5 and CHA5II, and the animal challenge studies, revealed that CHA5II induced the broadest protection profile. We concluded that CHA5II combined with electroporation delivery is a promising strategy to induce antibodies with broad cross-reactivities against divergent H5N1 influenza viruses.

subject areas

  • Amino Acid Sequence
  • Amino Acids
  • Animals
  • Antigens, Viral
  • Carbohydrate Metabolism
  • Cell Line
  • Cross Protection
  • Hemagglutinin Glycoproteins, Influenza Virus
  • Humans
  • Immune Sera
  • Influenza A Virus, H5N1 Subtype
  • Influenza Vaccines
  • Mice
  • Mice, Inbred BALB C
  • Microarray Analysis
  • Molecular Sequence Data
  • Mutation
  • Neutralization Tests
  • Orthomyxoviridae Infections
  • Polysaccharides
  • Protein Structure, Tertiary
  • Receptors, Virus
  • Vaccines, DNA
scroll to property group menus

Research

keywords

  • genotype
  • serotype
scroll to property group menus

Identity

PubMed Central ID

  • PMC3048126

International Standard Serial Number (ISSN)

  • 0027-8424

Digital Object Identifier (DOI)

  • 10.1073/pnas.1019744108

PubMed ID

  • 21321237
scroll to property group menus

Additional Document Info

start page

  • 3510

end page

  • 3515

volume

  • 108

issue

  • 9

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support